dynavax is a san francisco bay area biopharmaceutical company focused on discovering, developing and commercializing innovative products to treat and prevent allergies, infectious diseases, cancer and chronic inflammatory diseases. our primary proprietary approach is aimed at altering the immune system response in highly specific ways using iss, short dna sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.

Biopharm Biopharmaceutical Vaccine Hepatitis B Hepatitis C Cancer Allergy

Immunotherapy Ragweed Hay Fever Asthma Peanut Allergy Tlr-9 Toll Like Receptor

Contact:	510-848-5100
Address:	2929 7th St Ste 100 Berkeley, California   947102753 , USA
Url:	http://www.dynavax.com
Fax:	510-848-1376
Annual Sales:	US$10 Million - US$50 Million